Skip to main content

Portfolio

HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.

Overview as at 30 June 2019

Currency allocation of assets

Emphasis on US dollar investments

56 340 US dollar (USD) 64 Renminbi (CNY) 12 Euro (EUR) 10 Swiss franc (CHF) 6 Indian rupee (INR) 4 Other currencies (CAD, DKK, GBP, HDK, SEK) 4 #AD2D3C #B7D4D8 #2E516C #6d7333 #CD8699 #53465e #f2a58f #94743a #cfa400 #3880C0
Allocation of assets

Mainly invested in private companies or in companies originating
from the private companies portfolio.

62 340 Public companies 46 Private companies 32 Cash and cash equivalents 10 Funds 9 Other assets 3 #AD2D3C #B7D4D8 #2E516C #6d7333 #CD8699 #53465e #f2a58f #94743a #cfa400 #3880C0
Development phase of portfolio companies

Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.

69 90 Products on the market 20 Phase III 38 Phase II 18 Phase I 4 Preclinical 1 Profitable 19 #AD2D3C #B7D4D8 #2E516C #6d7333 #CD8699 #53465e #f2a58f #94743a #cfa400 #3880C0
Therapeutic area of the lead product of portfolio companies

Broadly diversified areas of activity.

79 350 Others 32 Orphan diseases 15 Oncology 15 Immunology/Inflammation 12 Central nervous system 11 Medical technology / diagnostics 5 Metabolic diseases 4 Digital Health 4 Infectious diseases 2 #AD2D3C #B7D4D8 #2E516C #6d7333 #CD8699 #53465e #f2a58f #94743a #cfa400 #3880C0